Martínez-González María Nancy, Mondragón-Sánchez Ricardo, Mondragón-Sánchez Alejandro, Gómez-Gómez Elvira, Garduño-López Ana Lilia, Bernal-Maldonado Rigoberto, Oñate-Ocaña Luis F, Ruiz-Molina Juan Manuel
Departamento de Gastroenterología, Instituto Nacional de Cancerología, México, D.F.
Rev Gastroenterol Mex. 2003 Oct-Dec;68(4):277-82.
Cavernous hemangioma is the most frequent focal liver lesion. It affects mainly women and may cause symptoms such as abdominal pain, mass, and early satiety, or complications such as heart failure or coagulopathy. There are several options for treatment in symptomatic patients. However, it seems that surgical resection is the only curative treatment.
Evaluate indications and results of liver resection in patients with cavernous hemangiomas and hepatic hemangiomatosis.
We conducted a retrospective analysis of clinical files of patients treated at the Instituto Nacional de Cancerología (INCan) and the Centro Médico ISSEMYM during a 8-year period. Epidemiological data as well as diagnostic work-up and treatment were analyzed.
From August 1995 to May 2003, 24 patients with liver hemangiomas were resected at both institutions. Twenty three were female (95.8%) and one, male (4.1%). Indications for surgery were presence of symptoms in 20 patients (83.3%), undefined diagnosis in three (12.5%), and rapid growth in one (4.1%). Most frequent symptoms were abdominal pain in 20 (83.3%) patients, followed by abdominal mass in five (20.8%), and early gastric satiety in four (16.6%). Abdominal computed tomography (CT) scan was the most frequent imaging study used in 22 patients (91.6%), followed by ultrasound in 20 (83.3%). Size of lesion ranged from 4-30 cm (X: 8.7 cm), 16 patients were submitted to formal liver resection (66.6%), and eight to enucleation (33.3%). Four patients presented operative complications (16.6%) that included postoperative bleeding in two (8.3%), fever in one (4.1%) and abdominal haematoma in one (4.1%). There was no operative mortality. Twenty two patients were asymptomatic at time of evaluation (91%).
This lesion affects mainly women, and presence of symptoms is the most common indication for treatment. Choice of surgical procedure to be carried out depends on location and morphology of the lesion. Liver resection or enucleation are safe forms of treatment that properly controlled symptomatology.
海绵状血管瘤是最常见的肝脏局灶性病变。它主要影响女性,可能导致腹痛、肿块和早饱等症状,或引发心力衰竭或凝血病等并发症。对于有症状的患者有多种治疗选择。然而,手术切除似乎是唯一的根治性治疗方法。
评估海绵状血管瘤和肝血管瘤病患者肝切除的指征及结果。
我们对国立癌症研究所(INCan)和ISSEMYM医疗中心在8年期间治疗的患者临床档案进行了回顾性分析。分析了流行病学数据以及诊断检查和治疗情况。
1995年8月至2003年5月,两家机构共对24例肝脏血管瘤患者进行了手术切除。23例为女性(95.8%),1例为男性(4.1%)。手术指征为20例患者有症状(83.3%),3例诊断不明确(12.5%),1例生长迅速(4.1%)。最常见的症状是20例(83.3%)患者出现腹痛,其次是5例(20.8%)出现腹部肿块,4例(16.6%)出现早期胃饱胀感。22例患者(91.6%)最常使用的影像学检查是腹部计算机断层扫描(CT),其次是20例(83.3%)使用超声检查。病变大小为4 - 30厘米(平均:8.7厘米),16例患者接受了正规肝切除(66.6%),8例接受了摘除术(33.3%)。4例患者出现手术并发症(16.6%),包括2例术后出血(8.3%)、1例发热(4.1%)和1例腹部血肿(4.1%)。无手术死亡病例。22例患者在评估时无症状(91%)。
这种病变主要影响女性,症状的出现是最常见的治疗指征。所采用的手术方式的选择取决于病变的位置和形态。肝切除或摘除术是安全的治疗方式,能有效控制症状。